14-day Premium Trial Subscription Try For FreeTry Free
$0.151
-0.0059 (-3.75%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.101 $0.240 Friday, 3rd May 2024 KTRA stock ended at $0.151. This is 3.75% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 8.34% from a day low at $0.150 to a day high of $0.162.
90 days $0.0810 $0.240
52 weeks $0.0810 $5.60

Historical Kintara Therapeutics Inc. prices

Date Open High Low Close Volume
May 03, 2024 $0.157 $0.162 $0.150 $0.151 2 777 494
May 02, 2024 $0.147 $0.162 $0.145 $0.157 3 421 452
May 01, 2024 $0.151 $0.155 $0.145 $0.148 1 776 223
Apr 30, 2024 $0.162 $0.162 $0.141 $0.155 4 772 653
Apr 29, 2024 $0.143 $0.165 $0.143 $0.163 8 409 574
Apr 26, 2024 $0.195 $0.195 $0.136 $0.149 50 979 698
Apr 25, 2024 $0.132 $0.165 $0.132 $0.158 11 052 096
Apr 24, 2024 $0.131 $0.143 $0.130 $0.137 5 776 728
Apr 23, 2024 $0.117 $0.143 $0.113 $0.133 7 525 248
Apr 22, 2024 $0.122 $0.123 $0.113 $0.114 2 194 492
Apr 19, 2024 $0.120 $0.127 $0.115 $0.121 7 108 280
Apr 18, 2024 $0.102 $0.107 $0.101 $0.107 1 670 442
Apr 17, 2024 $0.107 $0.108 $0.102 $0.104 1 779 071
Apr 16, 2024 $0.110 $0.111 $0.102 $0.107 2 660 364
Apr 15, 2024 $0.120 $0.122 $0.107 $0.110 2 563 155
Apr 12, 2024 $0.120 $0.128 $0.111 $0.125 4 616 637
Apr 11, 2024 $0.119 $0.127 $0.109 $0.124 2 934 928
Apr 10, 2024 $0.131 $0.131 $0.126 $0.128 2 092 224
Apr 09, 2024 $0.135 $0.136 $0.128 $0.132 3 682 079
Apr 08, 2024 $0.127 $0.145 $0.120 $0.135 7 566 646
Apr 05, 2024 $0.127 $0.135 $0.114 $0.130 13 543 230
Apr 04, 2024 $0.164 $0.168 $0.135 $0.144 20 832 852
Apr 03, 2024 $0.216 $0.240 $0.142 $0.164 222 656 524
Apr 02, 2024 $0.0946 $0.100 $0.0934 $0.100 3 152 574
Apr 01, 2024 $0.0980 $0.0988 $0.0925 $0.0980 3 534 759
Click to get the best stock tips daily for free!

About Kintara Therapeutics Inc.

Kintara Therapeutics. Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intri... KTRA Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT